Viking Therapeutics
Earnings Date & Report
Last updated:
Viking Therapeutics’s last earnings date was on 6 Feb 2024.
Viking Therapeutics stock Earnings report, Estimates & History
| 2019-08-01 | -0.13444 | -0.11 |
|---|---|---|
| 2019-11-05 | -0.05079 | -0.08 |
| 2020-02-26 | -0.07813 | -0.1 |
| 2020-04-30 | -0.13967 | -0.13 |
| 2020-07-29 | -0.11818 | -0.13 |
| 2020-10-28 | -0.11119 | -0.13 |
| 2021-02-17 | -0.14706 | -0.15 |
| 2021-04-28 | -0.20748 | -0.19 |
| 2021-07-28 | -0.20202 | -0.2 |
| 2021-11-03 | -0.13962 | -0.17 |
| 2022-02-09 | -0.13618 | -0.16 |
| 2022-04-27 | -0.22732 | -0.21 |
| 2022-07-27 | -0.24953 | -0.23 |
| 2022-10-26 | -0.19091 | -0.21 |
| 2022-12-31 | -0.16691 | -0.24514 |
| 2023-02-08 | -0.29164 | -0.26 |
| 2023-04-26 | -0.26042 | -0.25 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Viking Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 6 Feb 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 24 Oct 2023 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 25 Jul 2023 | N/A | -$0.24 | N/A | N/A | N/A | Earnings Call Transcript |
| 26 Apr 2023 | Beat | -$0.26 | -$0.25 | N/A | N/A | Earnings Call Transcript |
| 8 Feb 2023 | Beat | -$0.29 | -$0.26 | N/A | N/A | Earnings Call Transcript |
| 31 Dec 2022 | Missed | -$0.17 | -$0.25 | 6.92M | N/A | |
| 26 Oct 2022 | Missed | -$0.19 | -$0.21 | 7.32M | N/A | Earnings Call Transcript |
| 27 Jul 2022 | Beat | -$0.25 | -$0.23 | 5.91M | N/A | Earnings Call Transcript |
| 27 Apr 2022 | Beat | -$0.23 | -$0.21 | -6.57M | N/A | Earnings Call Transcript |
| 9 Feb 2022 | Missed | -$0.14 | -$0.16 | 3.33M | N/A | Earnings Call Transcript |
| 3 Nov 2021 | Missed | -$0.14 | -$0.17 | -2.10M | N/A | Earnings Call Transcript |
| 28 Jul 2021 | Beat | -$0.2 | -$0.2 | 1.53M | N/A | Earnings Call Transcript |
| 28 Apr 2021 | Beat | -$0.21 | -$0.19 | -3.79M | N/A | Earnings Call Transcript |
| 17 Feb 2021 | Missed | -$0.15 | -$0.15 | 1.09M | N/A | Earnings Call Transcript |
| 28 Oct 2020 | Missed | -$0.11 | -$0.13 | 3.14M | N/A | |
| 29 Jul 2020 | Missed | -$0.12 | -$0.13 | 3.04M | N/A | Earnings Call Transcript |
| 30 Apr 2020 | Beat | -$0.14 | -$0.13 | -3.82M | N/A | Earnings Call Transcript |
| 26 Feb 2020 | Missed | -$0.08 | -$0.1 | N/A | N/A | Earnings Call Transcript |
| 5 Nov 2019 | Missed | -$0.05 | -$0.08 | 3.03M | N/A | Earnings Call Transcript |
| 1 Aug 2019 | Beat | -$0.13 | -$0.11 | 1.67M | N/A | Earnings Call Transcript |
Viking Therapeutics Earnings report FAQs
When is Viking Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Viking Therapeutics's earnings date was on 8 Feb 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.